NYSE: CHE
Chemed Corp Earnings Dates, Reports, Calls

Chemed earnings were $290.3M for the trailing 12 months ending Jun 30, 2025, with -1.7% growth year over year. The latest CHE earnings report on Jun 30, 2025 announced Q2 2025 earnings of $52.5M, down 26.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CHE reported annual earnings of $302.0M, with 10.8% growth.

CHE past earnings growth

How has CHE's earnings growth performed historically?

Company
-1.65%
Industry
12.44%
Market
30.19%
CHE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CHE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CHE's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CHE earnings history

Current Revenue
$2.5B
Current Earnings
$290.3M
Current Profit Margin
11.6%
CHE's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CHE Return on Equity

Current Company
24.5%
Current Industry
-228.1%
Current Market
26.6%
CHE's Return on Equity (24.5%)... subscribe to Premium to read more.
High Return on Equity Performance

CHE undefined

Current Company
16.9%
Current Industry
7.1%
CHE is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CHE announces earnings.

CHE undefined

Current Company
26.8%
Current Industry
15.8%
CHE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CHE vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CHE$453.44M$290.35M+3.59%$19.61
OPCH$428.69M$211.25M+46.98%$1.26
ENSG$526.18M$322.80M+17.42%$5.67
DVA$2.39B$836.27M+10.52%$10.39
CON$364.58M$156.50M-25.57%$1.31

Chemed Earnings Reports & History FAQ

What were Chemed's earnings last quarter?

On CHE's earnings call on Invalid Date, Chemed (NYSE: CHE) reported Q2 2025 earnings per share (EPS) of $3.60, up 23.4% year over year. Total CHE earnings for the quarter were $52.49 million. In the same quarter last year, Chemed's earnings per share (EPS) was $4.70.

If you're new to stock investing, here's how to buy Chemed stock.

Is Chemed profitable or losing money?

As of the last Chemed earnings report, Chemed is currently profitable. Chemed's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $290.35 million, a 3.51% decrease year over year.

What was CHE's earnings growth in the past year?

As of Chemed's earnings date in Invalid Date, Chemed's earnings has grown -1.65% year over year. This is 14.09 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 12.44%. CHE earnings in the past year totalled $290.35 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.